Zimmer Biomet logo

Zimmer Biomet AI Adoption Tracker

Last updated: August 9, 2026

3.7 Good

Overview

Zimmer Biomet has positioned itself as a leader in AI-driven orthopedic innovation, developing an integrated ecosystem that connects surgical robotics, smart implants, and predictive analytics [1][2]. The company launched WalkAI in March 2022, the orthopedic industry's first AI model to predict patient gait speed recovery after hip and knee surgeries [3]. Their ZBEdge Connected Intelligence Suite combines robotics (ROSA platform), smart implants (Persona IQ), and patient monitoring (mymobility) to deliver data-powered clinical insights [4][5]. The acquisition of Monogram Technologies in October 2025 for $177 million positions Zimmer Biomet to become the first orthopedic company offering fully autonomous surgical robotics [6].

AI Maturity Index

3.7 /5 Practitioner

Evidence high

  • AI deployed across surgical robotics, patient monitoring, and predictive analytics [corporate]
  • Strategic partnerships with Microsoft Azure and multiple AI acquisitions [corporate]

Missing Evidence

  • No specific AI governance policy found publicly

Evidence medium

  • 7.8% non-tech AI mentions in hiring, with AI expectations in customer service and HR [jobs]
  • Comprehensive AI framework built on Azure with automated development workflows [corporate]

Missing Evidence

  • No specific AI training programs mentioned publicly

Evidence high

  • 15-minute OR time savings and 95% cup placement accuracy with AI systems [corporate]
  • 250,000+ patients using AI-powered mymobility platform [news]

Missing Evidence

  • All evidence present

Radar Comparison

Company Sector Avg

Peer Comparison: Zimmer Biomet vs healthcare

Based on 66 companies in sector

Dimension Zimmer Biomet Sector Avg Diff
Adoption 4.0 3.7 +0.3
Proficiency 3.0 3.5 -0.5
Impact 4.0 3.6 +0.4
Overall 3.7 3.6 +0.1

AI Hiring Signals

Zimmer Biomet Job Postings Analysis

10.8%
AI Mention Rate
102
Jobs Sampled
11
AI-Related Jobs
High Confidence
Data Quality

Tech vs Non-Tech AI Requirements

Tech Roles (Engineering/Data) 20.0%
Non-Tech Roles 7.8%

Top Departments by AI Mention Rate

Customer Service
33.3%
Engineering/Tech
23.1%
HR
18.2%
Data/Analytics
16.7%
Marketing
9.1%

Analysis

Zimmer Biomet shows moderate AI hiring emphasis at 10.8% overall, with tech roles leading at 20% but notable AI expectations spreading into customer service (33.3%) and HR (18.2%). The 7.8% non-tech AI mention rate indicates growing cross-functional AI fluency expectations.

View Sample Job Postings (8 sources)

Key Metrics

15 minutes average (79 vs 94 minutes)
OR time savings with fluoroscopic grid
Source: https://www.zimmerbiomet.com/content/dam/zb-corporate/en/products/specialties/orthogrid/orthogrid-hip-ai/4913.1-US-en%20OrthoGrid%20Hip%20AI%20Brochure-digital.pdf
95% within Lewinnek Safe Zone
Cup placement accuracy with Hip AI
Source: https://www.zimmerbiomet.com/en/products-and-solutions/specialties/orthogrid/orthogrid-hip-ai.html
Over 250,000 patients
mymobility platform users
Source: https://www.medicaldesignandoutsourcing.com/zimmer-biomet-seeks-a-zbedge-for-its-rosa-robotic-surgery/
5
AI Initiatives
Source: Larridin Analysis

AI Initiatives

1

Monogram Technologies Acquisition

July 2025

Active

Acquisition of AI-driven robotic surgery company for autonomous orthopedic procedures

Acquired for $177 million upfront plus contingent value rights up to $12.37 per share. Adds CT-based, semi-autonomous and fully autonomous robotic technologies. Technology received FDA 510(k) clearance in March 2025 and expected commercialization in early 2027.

Robotics
2

OrthoGrid Hip AI Integration

August 2024

Active

AI-powered fluoroscopy-based surgical assistance for total hip arthroplasty

Acquired OrthoGrid Systems in August 2024. Provides real-time image analysis, automated measurements, and guidance on cup placement. Features distortion correction and pelvic position tracking for reproducible surgical outcomes.

3

ZBEdge Analytics Platform

2024

Active

AI-driven data platform delivering intra-operative and recovery insights

Mobile platform that delivers mobility and outcome insights directly to surgeons' smartphones. Enables objective assessment of surgical performance and understanding of clinical decision impacts on patient recovery.

Frequently Asked Questions

WalkAI is an AI model that predicts patient gait speed recovery 90 days after hip or knee surgery by analyzing daily mobility data through the mymobility app and comparing it to anonymized real-world data from the ZBEdge database.

Their AI integrates across the ZBEdge ecosystem, connecting ROSA robotics data with patient monitoring through mymobility and smart implant data from Persona IQ to provide comprehensive pre-, intra-, and post-operative insights.

Through the Monogram acquisition, they're developing the first fully autonomous orthopedic surgical robot, featuring CT-based AI navigation that can perform procedures with minimal surgeon intervention while maintaining safety and precision.

Their OrthoGrid Hip AI system achieves 95% cup placement accuracy within the Lewinnek Safe Zone and provides 15-minute average time savings compared to traditional fluoroscopy methods.

The integrated AI ecosystem has enabled over 250,000 patients to use the mymobility platform for recovery monitoring, with early associations found between intraoperative data and post-operative outcomes through the OrthoIntel platform.

Related Companies

About AI Tracker

AI Tracker is a research project by Larridin, the AI execution intelligence platform.

Methodology: We analyze earnings calls, press releases, partnership announcements, and product documentation. All assessments are based solely on publicly available information—no private customer data is used.

Maturity Scoring: Each dimension is rated on a 4-tier scale (Nascent → Emerging → Scaling → Leading) based on evidence from public sources. Industry averages are computed as the median across all tracked companies in the sector.

Update cadence: Every 2-3 weeks
Last updated: August 9, 2026